Our visualization and diagnostic technology is designed to deliver precision answers to critical clinical questions, enabling clinicians to individualize patient treatment. The heterogeneous nature of tumors can lead to diverse responses to treatment across patients and regions of the same tumor. Our comprehensive approach addresses tumor heterogeneity by looking at the tumor in its entirety - beyond biopsies or 2D pathology slides.
Automatically segments the tumor and surrounding tissues to create a 3D model.
Captures the physics, chemistry and biology of a tumor at tissue and cellular levels to create a digital twin.
Create algorithms using patient datasets to customize characteristics and estimate long-term outcomes.
TumorSight Viz is our first U.S. FDA cleared product supporting breast cancer surgeons and patients in the visualization and analysis of DCE-MRI studies, prior to use in preoperative planning (e.g., breast conservation surgery). This cloud-based tool transforms 2D DCE MRIs into visually detailed and interactive 3D representations that enable calculations of key measurements (e.g. tumor volume, distance to key anatomical features).
*This device is not FDA cleared or approved
*This device is not FDA cleared or approved
©SimBioSys
